← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2011Last known activity
Mar 3, 2025
Timeline
2000s
- Jan 1, 2004
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia— Founded
Drugs by trial phase (22 distinct, 19 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Amyotrophic Lateral Sclerosis
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Fallopian Tube Neoplasms
- Heart Failure
- Hyperkinesis
- Ischemia
- Motor Neuron Disease
- Optic Nerve Diseases
- Optic Neuropathy, Ischemic
- Osteonecrosis
- Osteoporosis
- Ovarian Neoplasms
- Peritoneal Neoplasms
- Retinitis
- Retinitis Pigmentosa
- Sclerosis
- Spinal Fractures
- Urinary Bladder, Overactive
- Urinary Incontinence
- Urinary Tract Infections
Recent trials (21)
- NCT06646562Lead sponsorPhase 4Mar 3, 2025
- NCT06449430Lead sponsorN/AMay 28, 2024
- NCT04849065Lead sponsorPhase 2May 1, 2021
- NCT06127355Lead sponsorPhase 3Mar 3, 2021
- NCT04705987Lead sponsorPhase 3Feb 8, 2021
- NCT04707352Lead sponsorPhase 3Feb 8, 2021
- NCT06907082Lead sponsorN/ADec 28, 2020
- NCT06907082OfficialN/ADec 28, 2020
- NCT04350320Overall official - principal investigatorPhase 3Apr 20, 2020
- NCT04350320Lead sponsorPhase 3Apr 20, 2020
- NCT04348383Lead sponsorPhase 2Apr 8, 2020
- NCT03851562Lead sponsorPhase 2Jun 13, 2018
- NCT03468465Lead sponsorPhase 4May 4, 2018
- NCT02566681CollaboratorPhase 1Sep 1, 2015
- NCT02566655CollaboratorPhase 1Sep 1, 2015
Details
- Founded
- Murcia, ES Jan 1, 2004
- Last known activity
- Mar 3, 2025